Downregulation of Syndecan-1 induce glomerular endothelial cell dysfunction through modulating internalization of VEGFR-2

Cellular Signalling

Volumn 28, Issue 8, 2016, Pages 826-837

  Jing, Zhou ^a   Wei jie, Yuan ^a   Yi feng, Zhu Ge ^a   Jing, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Glomerular endothelial cell; Injury; Syndecan 1; VEGFR 2

Indexed keywords

CAVEOLIN; CLATHRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RAC1 PROTEIN; SMALL INTERFERING RNA; SYNDECAN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; PROTEIN BINDING; VASCULOTROPIN A;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENDOTHELIUM CELL; GLOMERULAR ENDOTHELIAL CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE; COMPLICATION; DISEASE MODEL; GENETIC TRANSFECTION; GLOMERULUS; HYPOXIA; ISCHEMIA; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; APOPTOSIS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOCYTOSIS; ENDOTHELIAL CELLS; HYPOXIA; ISCHEMIA; KIDNEY GLOMERULUS; MALE; MICE; PROTEIN BINDING; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYNDECAN-1; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84965078643     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.04.001     Document Type: Article

References (49)

1. Coca S.G., Yusuf B., Shlipak M.G., Garg A.X., Parikh C.R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 2009, 53:961-973.
2. Hsu C.Y., Chertow G.M., McCulloch C.E., Fan D., Ordoñez J.D., Go A.S. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin. J. Am. Soc. Nephrol. 2009, 4:891-898.
3. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 2011, 121:4210-4221.
4. Pollak M.R., Quaggin S.E., Hoenig M.P., Dworkin L.D. The glomerulus: the sphere of influence. Clin. J. Am. Soc. Nephrol. 2014, 9:1461-1469.
5. Jarad George, Miner Jeffrey H. Update on the glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 2009, 18:226-232.
6. Haraldsson B., Nyström J. The glomerular endothelium: new insights on function and structure. Curr. Opin. Nephrol. Hypertens. 2012, 21:258-263.
7. Satchell S. The role of the glomerular endothelium in albumin handling. Nat. Rev. Nephrol. 2013, 9:717-725.
8. Haraldsson B., Nyström J., Deen W.M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 2008, 88:451-487.
9. Havasi A., Borkan S.C. Apoptosis and acute kidney injury. Kidney Int. 2011, 80:29-40.
10. Heyman S.N., Rosenberger C., Rosen S. Acute kidney injury: lessons from experimental models. Contrib. Nephrol. 2011, 169:286-296.
11. Deen W.M. What determines glomerular capillary permeability?. J. Clin. Invest. 2004, 114:1412-1414.
12. Satchell S.C., Tasman C.H., Singh A., Ni L., Geelen J., von Ruhland C.J., O'Hare M.J., Saleem M.A., van den Heuvel L.P., Mathieson P.W. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 2006, 69:1633-1640.
13. Tuuminen R., Nykänen A.I., Saharinen P., Gautam P., Keränen M.A., Arnaudova R., Rouvinen E., Helin H., Tammi R., Rilla K., Krebs R., Lemström K.B. Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function. Am. J. Transplant. 2013, 13:2019-2034.
14. Solez K., Racusen L.C., Whelton A. Glomerular epithelial cell changes in early postischemic acute renal failure in rabbits and man. Am. J. Pathol. 1981, 103:163-173.
15. Weymouth R.J., Seibel H.R., Lee H.M., Hume D.M., Williams G.M. The glomerulus in man one hour after transplantation. An electron microscopic study. Am. J. Pathol. 1970, 58:85-104.
16. Carey D.J. Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 1997, 327:1-16.
17. Björnson A., Moses J., Ingemansson A., Haraldsson B., Sörensson J. Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am. J. Physiol. Ren. Physiol. 2007, 288:F748-F756.
18. Sarrazin S., Lamanna W.C., Esko J.D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 2011, 10.1101/cshperspect.a004952.
19. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68:729-777.
20. Manon-Jensen T., Itoh Y., Couchman J.R. Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 2010, 277:3876-3889.
21. Alexopoulou A.N., Multhaupt H.A., Couchman J.R. Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 2007, 39:505-528.
22. Lamorte S., Ferrero S., Aschero S., Monitillo L., Bussolati B., Omedè P., Ladetto M., Camussi G. Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia 2012, 26:1081-1090.
23. Yang Y., Yaccoby S., Liu W., Langford J.K., Pumphrey C.Y., Theus A., Epstein J., Sanderson R.D. Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 2002, 100:610-617.
24. Svennevig K., Kolset S.O., Bangstad H.J. Increased syndecan-1 in serum is related to early nephropathy in type 1 diabetes mellitus patients. Diabetologia 2006, 49:2214-2216.
25. Celie J.W., Katta K.K., Adepu S., Melenhorst W.B., Reijmers R.M., Slot E.M., Beelen R.H., Spaargaren M., Ploeg R.J., Navis G., van der Heide J.J., van Dijk M.C., van Goor H., van den Born J. Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation. Kidney Int. 2012, 81:651-661.
26. Sison K., Eremina V., Baelde H., Min W., Hirashima M., Fantus I.G., Quaggin S.E. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J. Am. Soc. Nephrol. 2012, 21:1691-1701.
27. Satchell S.C., Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am. J. Physiol. Ren. Physiol. 2009, 296:F947-F956.
28. Kanellis J., Mudge S.J., Fraser S., Katerelos M., Power D.A.R. Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury. Kidney Int. 2000, 57:2445-2456.
29. Humes H.D., Cieslinski D.A., Coimbra T.M., Messana J.M., Galvao C. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J. Clin. Invest. 1989, 84:1757-1761.
30. Xu Q., Chen X., Fu B., Ye Y., Yu L., Wang J., Li W., Cheng Q. Integrin alphavbeta3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells. Kidney Int. 1999, 56:1413-1422.
31. Akis N., Madaio M.P. Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int. 2004, 65:2223-2227.
32. Chen X.M. The Experimental Technique Operating Procedure of Nephrology 2011, 4-8. People's Military Medical Press, People's Republic of China.
33. Nakayama M., Nakayama A., van Lessen M., Yamamoto H., Hoffmann S., Drexler H.C., Itoh N., Hirose T., Breier G., Vestweber D., Cooper J.A., Ohno S., Kaibuchi K., Adams R.H. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat. Cell Biol. 2013, 15:249-260.
34. Dinesh N.V.S., Bhupathiraju K., Hu Xiaoke, Zhou Zehua, Fronczek Frank R., Couraud Pierre-Olivier, Romero Ignacio A., Weksler Babette, Graca M., Vicente H. Synthesis and in vitro evaluation of BBB permeability, tumor cell uptake, and cytotoxicity of a series of carboranylporphyrin conjugates. J. Med. Chem. 2014, 57:6718-6728.
35. Choi Y.A., Yoon Y.H., Choi K., Kwon M., Goo S.H., Cha J.S., Choi M.K., Lee H.S., Song I.S. Enhanced oral bioavailability of morin administered in mixed micelle formulation with pluronicF127 and tween 80 in rats. Biol. Pharm. Bull. 2015, 38:208-217.
36. Koch S., Tugues S., Li X., Gualandi L., Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011, 437:169-183.
37. Mehta R.L., Cerdá J., Burdmann E.A., Tonelli M., García-García G., Jha V., Susantitaphong P., Rocco M., Vanholder R., Sever M.S., Cruz D., Jaber B., Lameire N.H., Lombardi R., Lewington A., Feehally J., Finkelstein F., Levin N., Pannu N., Thomas B., Aronoff-Spencer E., Remuzzi G. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 2015, 385:2616-2643.
38. Horton R., Berman P. Eliminating acute kidney injury by 2025: an achievable goal. Lancet 2015, 385:2551-2552.
39. Jeansson M., Björck K., Tenstad O., Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J. Am. Soc. Nephrol. 2009, 20:114-122.
40. Sison K., Eremina V., Baelde H., Min W., Hirashima M., Fantus I.G., Quaggin S.E. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J. Am. Soc. Nephrol. 2010, 21:1691-1701.
41. Xu C., Chang A., Hack B.K., Eadon M.T., Alper S.L., Cunningham P.N. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int. 2014, 85:72-81.
42. Kanellis J., Paizis K., Cox A.J., Stacker S.A., Gilbert R.E., Cooper M.E., Power D.A. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kidney Int. 2012, 61:1696-1706.
43. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533.
44. Lampugnani M.G., Orsenigo F., Gagliani M.C., Tacchetti C., Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 2006, 174:593-604.
45. Zhang X., Simons M. Receptor tyrosine kinases endocytosis in endothelium: biology and signaling. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1831-1837.
46. Gampel A., Moss L., Jones M.C., Brunton V., Norman J.C., Mellor H. VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 2006, 108:2624-2631.
47. Yu Jun, Bergaya Sonia, Murata Takahisa, Alp Ilkay F., Bauer Michael P., Lin Michelle I., Drab Marek, Kurzchalia Teymuras V., Stan Radu V., Sessa William C. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 2006, 116:1284-1291.
48. Frank Philippe G., Lisanti Michael P. Role of caveolin-1 in the regulation of the vascular shear stress response. J. Clin. Invest. 2006, 116:1222-1225.
49. Heidari-Hamedani G., Vivès R.R., Seffouh A., Afratis N.A., Oosterhof A., van Kuppevelt T.H., Karamanos N.K., Metintas M., Hjerpe A., Dobra K., Szatmári T. Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma. Cell. Signal. 2015, 27:2054-2067.